Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Bone marrow transplantation. - 56, 8 (2021) , 2042, ISSN: 1476-5365
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2021
- Creator
- DOI
-
10.1038/s41409-021-01366-y
- URN
-
urn:nbn:de:bsz:25-freidok-2198108
- Rights
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
Time of origin
- 2021
Other Objects (12)
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long‐term follow‐up of 815 patients
Allogeneic stem cell transplantation in multiple myeloma
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia
Response to daratumumab-retreatment in patients with multiple myeloma
Reduced intensity conditioning prior autologous stem cell transplantation in elderly DLBCL patients
Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning
The impact of pulmonary function in patients undergoing autologous stem cell transplantation
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long‐term follow‐up of 815 patients
Allogeneic stem cell transplantation in multiple myeloma
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia
Response to daratumumab-retreatment in patients with multiple myeloma
Reduced intensity conditioning prior autologous stem cell transplantation in elderly DLBCL patients
Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning
The impact of pulmonary function in patients undergoing autologous stem cell transplantation
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long‐term follow‐up of 815 patients
Allogeneic stem cell transplantation in multiple myeloma
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia
Response to daratumumab-retreatment in patients with multiple myeloma
Reduced intensity conditioning prior autologous stem cell transplantation in elderly DLBCL patients
Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning
The impact of pulmonary function in patients undergoing autologous stem cell transplantation
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis